Motus GI Holdings Inc (MOTS)
Motus GI Holdings, Inc. is a healthcare company focused on medical technology in the United States. The company develops the Pure-Vu system, a device designed to help clear a poorly prepared gastrointestinal tract during colonoscopy procedures and to support upper gastrointestinal endoscopy. Motus GI Holdings was formerly known as Eight-Ten Merger Corp. and adopted its current name in November 2016. Founded in 2008, the company is based in Fort Lauderdale, Florida. Its common stock trades on OTC Markets under the ticker MOTS.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-MOTS
|
—
|
—
|
—
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
0.007 K
|
—
|
—
|
—
|
—
|
—
|
—
|